HEalth Advocate for Liver Transplant - Pilot
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT05700799
- Status
- Recruiting
Conditions
- Liver Transplant; Complications
- Pediatric ALL
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Health Advocate — BEHAVIORALThe Health Advocate intervention will include helping pediatric liver transplant recipients and their families address unmet household social needs (e.g., food insecurity), improve patient-provider communication, and enhance care coordination.
Study Details
The Health Advocate for Liver Transplant (HEAL-Tx) Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for pediatric liver transplant patients and measure acceptability and feasibility according to RE-AIM.
Key Dates
- Start date
- Mar 20, 2023
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: InterventionThis is a single arm pilot intervention.
Primary Outcome Measure
Changes in caregiver experience [ Time Frame: Baseline and 90 days ]
Central Contacts
- Sharad Wadhwani, MD, MPH510-428-3058
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Francisco | San Francisco | California | 94158 | Sharad Wadhwani, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- Umbilical Vessel Catheterization Under ECG Monitoring and GuidanceRecruiting · Stanford University · Palo Alto, California
- Angiotensin 2 for AKI After OLTPHASE4 · Enrolling By Invitation · University of California, Los Angeles · Los Angeles, California
- Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEsRecruiting · European Foundation for Study of Chronic Liver Failure · Los Angeles, California
- Using Augmented Reality to Promote Physical Activity in Children With Cerebral PalsyRecruiting · Children's Hospital Los Angeles · Los Angeles, California